1.Davaro, RE and Thirumalai, A (2007) Life-threatening complications of HIV infection. Journal of Intensive Care Medicine 22, 73–81.
2.Simoes, EA et al. (1987) Evidence for HTLV-III infection in prostitutes in Tamil Nadu (India). Indian Journal of Medical Research 85, 335–338.
4.Saha, MK et al. (2000) Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian Journal of Medical Research 111, 37–39.
5.Narain, JP et al. (1994) Risk factors for HIV transmission in India. AIDS (London, England) 8, S77–S82.
6.Arksey, H and O'Malley, L (2005) Scoping studies: towards a methodological framework. International Journal of Social Research Methodology 8, 19–32.
7.Mahanta, J et al. (2008) Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. AIDS (London, England) 22, S59–S68.
8.Kermode, M et al. (2009) Killing time with enjoyment: a qualitative study of initiation into injecting drug use in north-east India. Substance Use and Misuse 44, 1070–1089.
9.Armstrong, G et al. (2010) Opioid substitution therapy in Manipur and Nagaland, north-east India: operational research in action. Harm Reduction Journal 7, 29.
10.Kumar, MS et al. (2009) Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India: what has been established needs to be continued and expanded. Harm Reduction Journal 6, 4.
11.Armstrong, G, Humtsoe, C and Kermode, M (2011) HIV risk behaviours among injecting drug users in Northeast India following scale-up of a targeted HIV prevention programme. BMC Public Health 11, S9.
12.Chakrapani, V et al. (2011) Social-structural contexts of needle and syringe sharing behaviours of HIV-positive injecting drug users in Manipur, India: a mixed methods investigation. Harm Reduction Journal 8, 9.
13.Suohu, K et al. (2012) Understanding the association between injecting and sexual risk behaviors of injecting drug users in Manipur and Nagaland, India. Harm Reduction Journal 9, 40.
14.Medhi, GK et al. (2012) Size estimation of injecting drug users (IDU) using multiplier method in five districts of India. Substance Abuse Treatment, Prevention, and Policy 7, 9.
15.Kermode, M et al. (2012) Meeting the needs of women who use drugs and alcohol in North-east India – a challenge for HIV prevention services. BMC Public Health 12, 825.
16.Lalmuanpuii, M et al. (2013) Scale-up of a comprehensive harm reduction programme for people injecting opioids: lessons from north-eastern India. Bulletin of the World Health Organization 91, 306–312.
17.Kermode, M et al. (2013) Falling through the cracks: a qualitative study of HIV risks among women who use drugs and alcohol in Northeast India. BMC International Health and Human Rights 13, 9.
18.Armstrong, G et al. (2014) Injecting drug use in Manipur and Nagaland, Northeast India: injecting and sexual risk behaviours across age groups. Harm Reduction Journal 11, 27.
19.Goswami, P et al. (2014) An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India. International Journal of Drug Policy 25, 853–864.
20.Armstrong, G et al. (2015) Undiagnosed HIV among people who inject drugs in Manipur, India. AIDS Care 27, 288–292.
21.Ganju, D, Ramesh, S and Saggurti, N (2016) Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India. Harm Reduction Journal 13, 21.
22.Phukan, SK et al. (2017) An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India. Harm Reduction Journal 14, 41.
23.Mishra, RK et al. (2014) HIV risk behaviors of male injecting drug users and associated non-condom use with regular female sexual partners in north-east India. Harm Reduction Journal 11, 5.
24.Kermode, M et al. (2015) Sexual behaviours of men who inject drugs in northeast India. Harm Reduction Journal 12, 4.
25.Sarkar, R et al. (2009) Implementation of a multiregion hybridization assay to characterize HIV-1 strains detected among injecting drug users in Manipur, India. Intervirology 52, 175–178.
26.Mullick, R et al. (2010) Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants. Virus Research 147, 195–201.
27.Sarkar, K et al. (2010) HIV infection and host genetic mutation among injecting drug-users of northeastern states of India. Journal of Health, Population and Nutrition 28, 130–136.
28.Sarkar, R et al. (2012) Near full-length genomic characterization of a HIV type 1 BC recombinant strain from Manipur, India. Virus Genes 45, 201–206.
29.Sarkar, R et al. (2012) Emergence of a unique recombinant form of HIV-1 from Manipur (India). Journal of Clinical Virology 55, 274–277.
30.Sharma, AL et al. (2017) Molecular epidemiology of HIV-1 among the HIV infected people of Manipur, Northeastern India: emergence of unique recombinant forms. Journal of Medical Virology 89, 989–999.
31.Sharma, AL et al. (2016) Prevalence of drug resistance associated mutations among the anti retroviral therapy exposed HIV-1 infected individuals in Manipur, Northeast India. Current HIV Research 14, 360–370.
32.Kermode, M et al. (2016) High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India. Indian Journal of Medical Research 143, 348–356.
33.Jadadish Mahanta, BB, Das, HK and Chelleng, PK (2009) The risk of HIV and HCV infection among injection drug users in northeast India. AIDS Care 21, 1420–1424.
34.Medhi, GK et al. (2011) Spatial distribution and characteristics of injecting drug users (IDU) in five Northeastern states of India. BMC Public Health 11, 1–11.
35.James, J (2016) Dealing with drug-seeking behaviour. Australian Prescriber 39, 96–100.
36.Latkin, C et al. (2011) The relationship between social network factors, HIV, hepatitis C among injecting drug users in Chennai, India. Drug and Alcohol Dependence 117, 50–54.
37.Sartor, R. (1991) The social impact of drug abuse on community life. Medicine and Law 10, 205–208.
38.Hammett, TM et al. (2010) Female sexual partners of injection drug users in Vietnam: an at-risk population in urgent need of HIV prevention services. AIDS Care 22, 1466–1472.
39.Beyrer, C et al. (2000) Overland heroin trafficking routes and HIV-1 spread in south and South East Asia. AIDS (London, England) 14, 75–83.
40.Sharma, AL et al. (2018) Antiretroviral resistance, genotypic characterization and origin of Human Immunodeficiency Virus among the infected wives of Intravenous drug users in Manipur. Scientific Reports 8, 1.
41.Mahajan, AP et al. (2008) Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS (London, England) 22, S67–S79.
42.Tarakeshwar, N et al. (2006) Living with HIV infection: perceptions of patients with access to care at a non-governmental organization in Chennai, India. Culture Health & Sexuality 8, 407–421.
43.Ahmedani, BK (2011) Mental health stigma: society, individuals, and the profession. Journal of Social Work Values and Ethics 8, 41–416.
44.Valenzuela, C et al. (2015) HIV stigma as a barrier to retention in HIV care at a general hospital in Lima, Peru: a case-control study. AIDS Behaviour 19, 235–245.
45.McConnell, MJ et al. (2008) Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain. AIDS Research and Human Retroviruses 24, 881–887.
46.Seth, P (2010) Evolution of HIV-1 in India. Indian Journal of Virology 21, 3–7.
47.Arts, EJ and Hazuda, DJ (2012) HIV-1 antiretroviral drug therapy. Cold Spring Harbor Perspectives in Medicine 2, 1–21.
48.Shafer, RW and Schapiro, JM (2008) HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. AIDS Review 10, 67–84.
49.Manns, MP et al. (2017) Hepatitis C virus infection. Nature Reviews Disease Primers 3, 17006.
50.Lee, W and Dieterich, D (2004) Challenges in the management of HIV and hepatitis C virus co-infection. Drugs 64, 693–700.
51.Yang, R et al. (2014) Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center. International Journal of Infectious Diseases 28, 29–34.